| Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections MW Jøraholmen, N Škalko-Basnet, G Acharya, P Basnet European journal of pharmaceutical sciences 79, 112-121, 2015 | 124 | 2015 |
| Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect MW Jøraholmen, Ž Vanić, I Tho, N Škalko-Basnet International journal of pharmaceutics 472 (1-2), 94-101, 2014 | 109 | 2014 |
| PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha MW Jøraholmen, P Basnet, G Acharya, N Škalko-Basnet European Journal of Pharmaceutics and Biopharmaceutics 113, 132-139, 2017 | 85 | 2017 |
| Localized therapy of vaginal infections and inflammation: Liposomes-in-hydrogel delivery system for polyphenols MW Jøraholmen, P Basnet, MJ Tostrup, S Moueffaq, N Škalko-Basnet Pharmaceutics 11 (2), 53, 2019 | 51 | 2019 |
| Liposomes-in-hydrogel delivery system enhances the potential of resveratrol in combating vaginal chlamydia infection MW Jøraholmen, M Johannessen, K Gravningen, M Puolakkainen, ... Pharmaceutics 12 (12), 1203, 2020 | 35 | 2020 |
| The antimicrobial properties of chitosan can be tailored by formulation MW Jøraholmen, A Bhargava, K Julin, M Johannessen, N Škalko-Basnet Marine Drugs 18 (2), 96, 2020 | 34 | 2020 |
| Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance Ž Vanić, MW Jøraholmen, N Škalko-Basnet Advanced Drug Delivery Reviews 178, 113855, 2021 | 25 | 2021 |
| The expanded role of chitosan in localized antimicrobial therapy LM Hemmingsen, N Škalko-Basnet, MW Jøraholmen Marine Drugs 19 (12), 697, 2021 | 21 | 2021 |
| Altered Pseudomonas Strategies to Inhibit Surface Aspergillus Colonies G Sass, H Nazik, P Chatterjee, P Shrestha, MC Groleau, E Déziel, ... Frontiers in Cellular and Infection Microbiology 11, 734296, 2021 | 8 | 2021 |
| Toxicity Assessment of Resveratrol Liposomes-in-Hydrogel Delivery System by EpiVaginalTM Tissue Model MW Jøraholmen, P Damdimopoulou, G Acharya, N Škalko-Basnet Pharmaceutics 14 (6), 1295, 2022 | 6 | 2022 |
| A novel approach for the treatment of aerobic vaginitis: azithromycin liposomes-in-chitosan hydrogel A Čačić, D Amidžić Klarić, S Keser, M Radiković, Z Rukavina, ... Pharmaceutics 15 (5), 1356, 2023 | 2 | 2023 |
| Advanced Drug Delivery Systems for Biologics MW Jøraholmen, S Ternullo, AM Holsæter, GE Flaten, N Škalko‐Basnet Fundamentals of Drug Delivery, 231-261, 2021 | 1 | 2021 |
| Development of chitosan-coated liposomes for improved therapy of vaginal infections: clotrimazole as model drug MWB Jøraholmen Universitetet i Tromsø, 2012 | 1 | 2012 |
| Texture characterization of chitosan-based liposomal hydrogels for dermal delivery of azithromycin Z Rukavina, MW Jøraholmen, N Škalko-Basnet, D Božić, ... EUFEPS Annual Meeting 2023, 127-127, 2023 | | 2023 |
| P 25 Vesicle-based resveratrol formulation for the topical treatment of Trichomonas vaginalis caused vaginal infection and inflammation P Basnet, MW Jøraholmen, G Acharya, N Skalko-Basnet Pregnancy Hypertension: An International Journal of Women's Cardiovascular …, 2017 | | 2017 |
| Surface modification of liposomes increases drug efficacy in local vaginal therapy MW Jøraholmen UiT The Arctic University of Norway, 2016 | | 2016 |
| Kan nanopartikulære formuleringer bedre behandlingen av genitale infeksjoner? MW Jøraholmen, G Acharya, N Skalko-Basnet | | 2015 |
| Pharmaceutical Sciences MW Jøraholmen, N Škalko-Basnet, G Acharya, P Basnet | | 2015 |
| Chitosan-coating as a mean to prolong vaginal residence time: Liposomes with clotrimazole MW Jøraholmen, Ž Vanić, I Tho, N Škalko-Basnet 3rd Conference on „Innovation in Drug Delivery: Advances in Local Drug Deliv, 2013 | | 2013 |
